Candel Therapeutics Inc

NASDAQ:CADL   10:57:48 AM EDT
9.34
-0.23 (-2.40%)
Earnings Announcements

Candel Posts Quarterly Loss Per Share $0.69

Published: 11/12/2021 14:46 GMT
Candel Therapeutics Inc (CADL) - Candel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights.
Candel Therapeutics Inc - Expects That Its Existing Cash and Cash Equivalents Will Be Sufficient to Fund Its Operations Into Q2 of 2023.
Candel Therapeutics Inc - Qtrly Loss per Share $0.69.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0.03 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.